Shanghai Kehua Bio-Engineering Co.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 1,904.22 million compared to CNY 5,382.82 million a year ago. Revenue was CNY 1,904.22 million compared to CNY 5,382.82 million a year ago.

Net loss was CNY 19.95 million compared to net income of CNY 1,192.04 million a year ago. Basic loss per share from continuing operations was CNY 0.0388 compared to basic earnings per share from continuing operations of CNY 2.3178 a year ago. Diluted loss per share from continuing operations was CNY 0.0388 compared to diluted earnings per share from continuing operations of CNY 2.2102 a year ago.